41 – 50 of 68
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Targeted immunotherapies overtaking emerging oncology market value based growth
(
- Contribution to journal › Letter
-
Mark
Community-acquired pneumonia : economics of inpatient medical care vis-à-vis clinical severity
2015) In Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia 41(1). p.48-57(
- Contribution to journal › Article
-
Mark
Accessibility and affordability of alcohol dependency medical care in serbia
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Evolution of the Serbian pharmaceutical market alongside socioeconomic transition
(
- Contribution to journal › Article
-
Mark
Radiation therapy remains the key cost driver of oncology inpatient treatment
(
- Contribution to journal › Article
- 2014
-
Mark
Costs differences among monoclonal antibodies-based first-line oncology cancer protocols for breast cancer, colorectal carcinoma and non-Hodgkin's lymphoma
(
- Contribution to journal › Article
-
Mark
LAT software induced savings on medical costs of alcohol addicts' care--results from a matched-pairs case-control study
(
- Contribution to journal › Article
-
Mark
10th World IHEA and ECHE Joint Congress : health economics in the age of longevity
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Contemporary generic market in Japan - key conditions to successful evolution
(
- Contribution to journal › Scientific review
- 2013
-
Mark
A ten-year study of depressive symptoms in Serbian medical students
(
- Contribution to journal › Article